Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markersAndré Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
The Lancet. Oncology|June 12, 2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Katleen De Preter, Arlene Naranjo, et al.
Digestive Diseases and Sciences|July 17, 2020
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA RegistryAlicia Algaba, Iván Guerra, Elena Ricart, et al.
Journal of Crohn'S & Colitis|September 24, 2020
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA RegistryMaría Chaparro, Ana Garre, Francisco Mesonero, et al.
Journal of Clinical Medicine|July 9, 2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCUSabino Riestra, Carlos Taxonera, Yamile Zabana, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2018
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registryMaría Chaparro, Ana Garre, Elena Ricart, et al.
Postgraduate Medical Journal|June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA projectCarlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Pharmaceutics|May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDACelia Gómez-Labrador, Elena Ricart, Marisa Iborra, et al.
Therapeutic Advances in Gastroenterology|March 6, 2024
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Digestive Diseases (Basel, Switzerland)|March 7, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA RegistryIván Guerra, Francisco Barros, María Chaparro, et al.
Pageof 8